Biliary Tract Cancers Detailed Epidemiology Segmentation Perspective by DelveInsight

Biliary Tract Cancers Detailed Epidemiology Segmentation Perspective by DelveInsight

(Albany, US) DelveInsight has launched a new report on Biliary Tract Cancers Epidemiology


DelveInsight’s ‘Biliary Tract Cancers (BTCs) Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Biliary Tract Cancers (BTCs) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Biliary Tract Cancer (BTC), also known as Cholangiocarcinoma (CCA) is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation. The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules (canals of Hering) to the ampulla of Vater, as well as at the peribiliary glands (intramural and extramural) and sometimes may affect gall bladder. Inflammation, cholestasis and receptor tyrosine kinases such as IL-6 receptor, c-MET and the EGFR family members are key signaling pathways in cholangiocarcinogenesis.


View Free sample page: –


Biliary Tract Cancers Epidemiology

As per DelveInsight estimates, total diagnosed incident population of Cholangiocarcinoma (CCA) in the 7MM ranges 18,470 in 2017. Among all the countries, the estimates show higher incidence of Cholangiocarcinoma in the United States. The Biliary Tract Cancers (BTCs) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Biliary Tract Cancers (BTCs) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Biliary Tract Cancers (BTCs) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Key facts of the report

  • Among the EU5 countries, Germany had the highest incident population of Cholangiocarcinoma (CCA) with 4,471 cases, followed by Italy and the United Kingdom
  • As per DelveInsight insights, the incidence rate varied based on type specific cases and the estimates showed an increasing trend in the Intrahepatic CCA cases, while Extrahepatic CCA showed a decreasing trend or in some are stable cases
  • DelveInsight’s assessment based on the recent studies suggests that overall 37% of the CCA cases belongs to US in the 7MM for the study period of 2017
  • Spain had the lowest incident population. As per our estimates, Japan had 4287 incident cases of Cholangiocarcinoma (CCA) in 2017


Biliary Tract Cancers Report Scope

  • The Biliary Tract Cancers (BTCs) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Biliary Tract Cancers (BTCs) Epidemiology Report and Model provide an overview of the risk factors and global trends of Biliary Tract Cancers (BTCs) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Biliary Tract Cancers (BTCs) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Biliary Tract Cancers (BTCs)
  • The report provides the segmentation of the Biliary Tract Cancers (BTCs) epidemiology


Download free sample page:-


Table of content

1. Key Insights 

2. Executive Summary of Biliary Tract Cancers (BTCs)

3. Biliary Tract Cancers (BTCs): Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight


Why should you buy this report?

 The Biliary Tract Cancers (BTCs) Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Biliary Tract Cancers (BTCs) market
  • Quantify patient populations in the global Biliary Tract Cancers (BTCs) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Biliary Tract Cancers (BTCs) therapeutics in each of the markets covered
  • Understand the magnitude of Biliary Tract Cancers (BTCs) population by its epidemiology
  • The Biliary Tract Cancers (BTCs) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Related Reports


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States